Saturday, July 11, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase II Pipeline Programs

Proof-of-concept and dose-finding clinical programs in Phase II development.

Programs 7,238
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 7,238 phase ii pharmaceutical pipeline programs from ClinicalTrials.gov. Proof-of-concept and dose-finding clinical programs in Phase II development.

Top sponsors

Pipeline programs

Page 30 of 151

  1. Buprenorphine soluble film

    Indivior Pty Ltd

    Opioid-related Disorders

    phase 2 small molecule completed

    1 trial

  2. Buprenorphine/naloxone Film Strip

    Indivior Pty Ltd

    Opioid-Related Disorders

    phase 2 small molecule completed

    1 trial

  3. Bupropion

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 2 small molecule completed

    1 trial

  4. Bupropion

    BRIGHT MINDS BIOSCIENCES INC.

    Methamphetamine

    phase 2 small molecule completed

    1 trial

  5. Bupropion

    BRIGHT MINDS BIOSCIENCES INC.

    Methamphetamine Dependence

    phase 2 small molecule completed

    1 trial

  6. Bupropion

    BRIGHT MINDS BIOSCIENCES INC.

    Amphetamine-Related Disorders

    phase 2 small molecule active

    2 trials

  7. Bupropion

    BRIGHT MINDS BIOSCIENCES INC.

    Schizophrenia and Disorders With Psychotic Features

    phase 2 small molecule completed

    1 trial

  8. Bupropion

    BRIGHT MINDS BIOSCIENCES INC.

    Marijuana Abuse

    phase 2 small molecule completed

    1 trial

  9. Bupropion

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Abuse

    phase 2 small molecule completed

    1 trial

  10. Bupropion SR 150mg tabs

    BRIGHT MINDS BIOSCIENCES INC.

    Adolescent Methamphetamine Abuse

    phase 2 small molecule completed

    1 trial

  11. Bupropion and NRT

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    phase 2 small molecule completed

    1 trial

  12. Buspirone

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 2 small molecule completed

    1 trial

  13. Busulfan

    Children's Hospital of Fudan University

    Juvenile Myelomonocytic Leukemia

    phase 2 small molecule completed

    1 trial

  14. Busulfan /ml concentrate for High-risk myeloïd malignancies

    The George Institute

    High-risk myeloïd malignancies

    phase 2 small molecule active

    1 trial

  15. Busulfan Koanaa /ml Konzentrat zur Herstellun...

    Fondazione Telethon ETS

    transfusion-dependent beta-thalassemia

    phase 2 small molecule active

    1 trial

  16. Byetta 10 micrograms solution for injection in pre-filled pen

    The George Institute

    Hypopituarism

    phase 2 small molecule active

    1 trial

  17. Byfavo 20 mg powder for solution for injection

    Disc Medicine

    stress anxiety, anxiety

    phase 2 small molecule active

    1 trial

  18. Byooviz 10 mg/ml solution for injection

    Samsung Bioepis NL B.V.

    Neovascular Age-Related Macular Degeneration (AMD), Macular Oedema Secondary to Retinal Vein Occlusion (RVO), Myopic Choroidal Neovascularization (mCNV)

    phase 2 small molecule active

    1 trial

  19. C-145-04

    Iovance Biotherapeutics B.V.

    Recurrent, metastatic, or persistent Cervical Carcinoma

    phase 2 small molecule active

    1 trial

  20. C-CAR088

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Multiple Myeloma

    phase 2 small molecule active

    2 trials

  21. C1 Esterase Inhibitor Injection [Cinryze]

    Takeda

    Subarachnoid Hemorrhage, Aneurysmal

    phase 2 small molecule active

    1 trial

  22. C1 Inhibitor, Human

    Takeda

    Traumatic Brain Injury

    phase 2 small molecule active

    1 trial

  23. C105

    COGNITION THERAPEUTICS INC

    Cognition Disorders

    phase 2 small molecule completed

    1 trial

  24. C1131003

    Pfizer Australia Pty Ltd

    Primary immune thrombocytopenia

    phase 2 small molecule active

    1 trial

  25. C12-48

    The George Institute

    Recessive dystrophic epidermolysis bullosa (RDEB)

    phase 2 small molecule active

    1 trial

  26. C16G2

    Armata Pharmaceuticals

    Dental Caries

    phase 2 small molecule completed

    3 trials

  27. C16G2 Gel

    Armata Pharmaceuticals

    Dental Caries

    phase 2 small molecule completed

    1 trial

  28. C16G2 Rinse

    Armata Pharmaceuticals

    Dental Caries

    phase 2 small molecule completed

    1 trial

  29. C16G2 Strip

    Armata Pharmaceuticals

    Dental Caries

    phase 2 small molecule completed

    1 trial

  30. C16G2 Varnish

    Armata Pharmaceuticals

    Dental Caries

    phase 2 small molecule completed

    1 trial

  31. C225 (cetuximab)

    The First People's Hospital of Lianyungang

    Nasopharyngeal Carcinoma

    phase 2 small molecule completed

    1 trial

  32. C3601010

    Pfizer Australia Pty Ltd

    Sepsis, Suspected or Confirmed Infections Due to Gram-Negative Pathogens Requiring Intravenous Antibiotic Treatment, Complicated Urinary Tract Infection, Blood Stream Infection, Hospital-acquired pneumonia or ventilator-associated pneumonia, Complicated Intra-abdominal Infection

    phase 2 small molecule active

    1 trial

  33. C3651003

    Pfizer Australia Pty Ltd

    Cancer cachexia

    phase 2 small molecule active

    1 trial

  34. C3651011

    Pfizer Australia Pty Ltd

    Heart failure

    phase 2 small molecule active

    1 trial

  35. C4161001

    Pfizer Australia Pty Ltd

    Breast Cancer, Ovarian Cancer, SCLC (Part 1 also had TNBC and NSCLC)

    phase 2 small molecule active

    1 trial

  36. C4221008

    Pfizer Australia Pty Ltd

    Non-small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  37. C4221022

    Pfizer Australia Pty Ltd

    MSI-H/dMMR metastatic colorectal cancer

    phase 2 small molecule active

    1 trial

  38. C4221023

    Pfizer Australia Pty Ltd

    Metastatic or unresectable locally advanced BRAF V600E/K mutation positive melanoma

    phase 2 small molecule active

    1 trial

  39. C4391025

    Pfizer Australia Pty Ltd

    HORMONE RECEPTOR-POSITIVE, HER2-NEGATIVE BREAST CANCER

    phase 2 small molecule active

    1 trial

  40. C4531002

    Pfizer Australia Pty Ltd

    Moderate-Severe Atopic Dermatitis

    phase 2 other active

    1 trial

  41. C4531029

    Pfizer Australia Pty Ltd

    Moderate-to-severe Asthma

    phase 2 other active

    1 trial

  42. C4921003

    Pfizer Australia Pty Ltd

    Heart failure

    phase 2 small molecule active

    1 trial

  43. C4971006

    Pfizer Australia Pty Ltd

    Relapsed/Refractory Diffuse Large B Cell Lymphoma

    phase 2 small molecule active

    1 trial

  44. C5041018

    Pfizer Australia Pty Ltd

    Ulcerative Colitis

    phase 2 small molecule active

    1 trial

  45. C5541010

    Pfizer Australia Pty Ltd

    Obesity, Overweight

    phase 2 small molecule active

    1 trial

  46. C6231002

    Pfizer Australia Pty Ltd

    Atopic Dermatitis

    phase 2 small molecule active

    1 trial

  47. C6461008

    Pfizer Australia Pty Ltd

    ADVANCED OR METASTATIC RENAL CELL CARCINOMA

    phase 2 small molecule active

    1 trial

  48. C6461013

    Pfizer Australia Pty Ltd

    Unresectable Locally Advanced or Metastatic Hepatocellular Carcinoma

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many Phase II pipeline programs are in the directory?

7,238 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.